+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticholinergic"

Generic Central Nervous System Drugs Market Report 2025 - Product Thumbnail Image

Generic Central Nervous System Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Parkinson's Disease Global Market Report 2025 - Product Thumbnail Image

Parkinson's Disease Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Vertigo Drugs - Global Strategic Business Report - Product Thumbnail Image

Vertigo Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 267 Pages
  • Global
From
Dystonia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dystonia Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 369 Pages
  • Global
From
Hyoscine - Global Strategic Business Report - Product Thumbnail Image

Hyoscine - Global Strategic Business Report

  • Report
  • July 2025
  • 281 Pages
  • Global
From
From
From
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 382 Pages
  • Global
From
Parkinson's Disease Market Report and Forecast 2025-2034 - Product Thumbnail Image

Parkinson's Disease Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Vertigo Market Report and Forecast 2025-2034 - Product Thumbnail Image

Vertigo Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Parkinsons Disease Market - Product Thumbnail Image

Parkinsons Disease Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
From
From
Dystonia - Pipeline Insight, 2025 - Product Thumbnail Image

Dystonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cataplexy - Pipeline Insight, 2025 - Product Thumbnail Image

Cataplexy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Parkinson's Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Parkinson's Disease Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Parkinson's Disease Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Parkinson's Disease Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

Anticholinergic drugs are a class of medications that act on the neurotransmitter acetylcholine in the central nervous system. They are used to treat a variety of conditions, including Parkinson's disease, overactive bladder, and gastrointestinal disorders. Anticholinergics work by blocking the action of acetylcholine, which is responsible for transmitting signals between nerve cells. This can help reduce muscle spasms, improve bladder control, and reduce gastrointestinal symptoms. Anticholinergics are available in both prescription and over-the-counter forms. Commonly prescribed anticholinergics include trihexyphenidyl, benztropine, and oxybutynin. Over-the-counter anticholinergics include diphenhydramine and hyoscyamine. Several pharmaceutical companies produce anticholinergic drugs, including Pfizer, GlaxoSmithKline, Merck, and Novartis. Generic versions of anticholinergics are also available from a variety of manufacturers. Show Less Read more